LINC00905

Across TCGA pan-cancer cohorts, LINC00905 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC00905 data layer compared with 1 for mutation status.

The strongest signal is observed in mesothelioma (MESO), where higher LINC00905 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00905 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

MESO, LIHC, and READ are the cancer types where LINC00905 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.149	0.567	<.001	126	view →
LIHC	OS	Tertile	All	0.278	0.588	<.001	63	view →
READ	OS	Tertile	II,III,IV	0.305	0.850	<.001	63	view →
KIRC	DFS	Tertile	IV	0.289	0.660	.008	30	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
LGG	OS	Tertile	All	0.336	0.550	.002	21	view →
LUAD	OS	Tertile	IV	0.114	0.560	.038	18	view →
LUSC	DFS	Tertile	II,III,IV	0.139	0.663	.027	15	view →
ACC	OS	Tertile	All	0.273	0.818	.031	9	view →
SKCM	DFS	Tertile	IV	0.134	0.589	.031	9	view →
HNSC	OS	Tertile	All	0.876	0.677	.043	6	view →
BLCA	OS	Tertile	II,III,IV	0.751	0.415	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC00905–MESO (OS)

Open the MESO breakdown →